Table 3 Occurrence of gout in patients hospitalised with multiple sclerosis (MS), Parkinson’s disease (PD) and motor neuron disease (MND) by time interval: observed (O) and expected (E) number of cases in each cohort, relative risk (RR) with 95% confidence intervals (95% CI) in the exposure cohort compared with the reference cohort
MS before gout | PD before gout | MND before gout | |||||||
|---|---|---|---|---|---|---|---|---|---|
Time interval | O | E | RR (95% CI) | O | E | RR (95% CI) | O | E | RR (95% CI) |
Overall | 246 | 311.7 | 0.79 (0.69-0.89) | 1521 | 1825 | 0.83 (0.79-0.87) | 83 | 88.4 | 0.94 (0.75-1.16) |
<1 yr | 50 | 43.1 | 1.16 (0.86-1.53) | 522 | 489 | 1.07 (0.98-1.17) | 41 | 29.9 | 1.38 (0.99-1.87) |
1-4 yrs | 96 | 126.4 | 0.76 (0.61-0.93) | 728 | 893.2 | 0.85 (0.79-0.92) | 34 | 35.5 | 0.96 (0.66-1.34) |
5+ yrs | 100 | 142.2 | 0.70 (0.57-0.85) | 231 | 442.8 | 0.52 (0.45-0.59) | 8 | 23.0 | 0.35 (0.15-0.68) |